17th Conference on Retroviruses and Opportunistic Infections (CROI), 16-19 February 2010, San Francisco
The 17th Conference on Retroviruses and Opportunistic Infections (CROI), one of the most important annual HIV meetings, was held this year from 16-19 February.
As with previous meetings, much of the conference is published online including all abstracts and webcasts of oral presentations including poster discussions.
Making this scientific content available without login or subscription is itself a significant achievement. It is a model for broadening access to medical research to a degree that is currently unmatched by any other meeting.
The webcasts this year include oral presentations, poster discussions, the opening lectures and the pre-meeting set of training workshops for young investigators.
The conference website also includes a searchable abstract database.
We encourage readers to view these lectures directly.
Lectures are also available as audio downloads and podcasts which include slides as audiobooks.
Our first articles covering this meeting are:
- href=”http://i-base.info/htb/10264″>ACTG 5205: atazanavir/ritonavir vs efavirenz in treatment naive patients
- Clinical benefits of stopping smoking: CVD and CHD risk
returns to that of previous smoker in HIV-positive people within three years
- HIV-positive people in the HOPS cohort have 4-fold risk of fracture
compared to general population in the US
- href=”http://i-base.info/htb/10248″>Vitamin D deficiencies in HIV management
- OCTANE 2: nevirapine
and lopinavir/r are similar when used with tenofovir and FTC in treatment-naive women
title=”Permanent link to Efavirenz use in pregnancy and birth outcomes” rel=”bookmark” href=”http://i-base.info/htb/10240″>Efavirenz use in pregnancy and
- href=”http://i-base.info/htb/10238″>Pregnancy outcomes in women using non-AZT HAART in Europe
More to follow next issue…